Sulindac suppresses tumorigenesis in the Min mouse

Carcinogenesis

Volumn 17, Issue 8, 1996, Pages 1757-1760

  Beazer Barclay, Yasmin ^a   Levy, Daniel B ^a   Moser, Amy R ^b   Dove, William F ^c   Hamilton, Stanley R ^a   Vogelstein, Bert ^a   Kinzler, Kenneth W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULINDAC;

ADENOMATOUS POLYP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COLORECTAL TUMOR; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; FEMALE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029739519     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.8.1757     Document Type: Article

References (41)

1. Groden, J., Thliveris, A., Samovitz, W. et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66, 589-600.
2. Joslyn, G., Carlson, M., Thliveris, A. et al. (1991) Identification of deletion mutations and three new genes at the familial polyposis locus. Cell, 66, 601-613.
3. Kinzler, K.W., Nilbert, M.C., Su, L.K. et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science, 253, 661-665.
4. Nishisho, I., Nakamura, Y., Miyoshi, Y. et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-669.
5. Miyoshi, Y., Nagase, H., Ando, H. et al. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet., 1, 229-233.
6. Powell, S.M., Zilz, N., Beazer-Barclay, Y., Bryan, T.M., Hamilton, S.R., Thibodeau, S.N., Vogelstein, B. and Kinzler, K.W. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
7. Smith, K.J., Johnson, K.A., Bryan, T.M. et al. (1993) The APC gene product in normal and tumor cells. Proc. Natl Acad. Sci. USA, 90, 2846-2850.
8. Jen, J., Powell, S.M., Papadopoulos, N., Smith, K.J., Hamilton, S.R., Vogelstein, B. and Kinzler, K.W. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54, 5523-5526.
9. Smith, A.J., Stern, H.S., Penner, M., Hay, K., Mitri, A., Bapat, B.V. and Gallinger, S. (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54, 5527-5530.
10. Moser, A.R., Pitot, H.C. and Dove, W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
11. Su, L.K., Kinzler, K.W., Vogelstein, B., Preisinger, A.C., Moser, A.R., Luongo, C., Gould, K.A. and Dove, W.F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670.
12. Fodde, R., Edelmann, W., Yang, K. et al. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl Acad. Sci. USA, 91, 8969-8973.
13. Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C., Borenstein, N. and Dove, W. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75, 631-639.
14. Kune, G.A., Kune, S. and Watson, L.F. (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48, 4399-4404.
15. Rosenberg, L., Palmer, J.R., Zauber, A.G., Warshauer, M.E., Stolley, P.D. and Shapiro, S. (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl Cancer Inst., 83, 355-358.
16. Thun, M.J., Namboodiri, M.M. and Heath, C.W., Jr (1991) Aspirin use and reduced risk of fatal colon cancer. New Engl. J. Med., 325, 1593-1596.
17. Logan, R.F., Little, J., Hawtin, P.G. and Hardcastle, J.D. (1993) Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br. Med. J., 307, 285-289.
18. Giovannucci, E., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Ascherio, A. and Willett, W.C. (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Annls Internal Med., 121, 241-246.
19. Peleg, I.I., Maibach, H.T., Brown, S.H. and Wilcox, C.M. (1994) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Internal Med., 154, 394-399.
20. Waddell, W.R., Ganser, G.F., Cerise, E.J. and Loughry, R.W. (1989) Sulindac for polyposis of the colon. Am. J. Surg., 157, 175-179.
21. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M. and Attali, P. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101, 635-639.
22. Rigau, J., Pique, J.M., Rubio, E., Planas, R., Tarrech, J.M. and Bordas, J.M. (1991) Effects of long-term sulindac therapy on colonic polyposis. Annls Internal Med., 115, 952-954.
23. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R. and Offerhaus, G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New Engl. J. Med., 328, 1313-1316.
24. Winde, G., Gumbinger, H.G., Osswald, H., Kemper, F. and Bunte, H. (1993) The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int. J. Colorectal Dis., 8, 13-17.
25. Shoemaker, A.R., Moser, A.R. and Dove, W.F. (1995) N-Ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res., 55, 4479-4485.
26. Reeves, P.G., Nielsen, F.H. and Fahey, G.C., Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr., 123, 1939-1951.
27. Reeves, P.G., Rossow, K.L. and Lindlauf, J. (1993) Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J. Nutr., 123, 1923-1931.
28. Kennedy, A.R., Beazer-Barclay, Y., Kinzler, K.W. and Newberne, P.M. (1996) Suppression of carcinogenesis in the intestines of Min mice by the soybean-derived Bowman-Birk Inhibitor. Cancer Res., 56, 679-682.
29. Park, C.M., Reid, P.E., Walker, D.C. and MacPherson, B.R. (1987) A simple, practical 'swiss roll' method of preparing tissues for paraffin or methacrylate embedding. J. Microsc., 145, 115-120.
30. Metzger, U., Meier, J., Uhlschmid, G. and Weihe, H. (1984) Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis. Colon Rectum, 27, 366-369.
31. Narisawa, T., Hermanek, P., Habs, M. and Schmahl, D. (1984) Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J. Cancer Res. Clin. Oncol., 108, 239-242.
32. Reddy, B.S., Maruyama, H. and Kelloff, G. (1987) Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47, 5340-5346.
33. Moorghen, M., Ince, P., Finney, K.J., Sunter, J.P., Appleton, D.R. and Watson, A.J. (1988) A protective effect of sulindac against chemically-induced primary colonic tumours in mice. J. Pathol., 156, 341-347.
34. Pollard, M. and Luckert, P.H. (1989) Prevention and treatment of primary intestinal tumors in rats by piroxicam. Cancer Res., 49, 6471-6473.
35. Skinner, S.A., Penney, A.G. and Pe, O.B. (1991) Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch. Surg., 126, 1094-1096.
36. Reddy, B.S., Rao, C.V., Rivenson, A. and Kelloff, G. (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497.
37. Tsujii, M. and Dubois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
38. Piazza, G.A., Rahm, A.L.K., Krutzsch, M. et al. (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55, 3110-3116.
39. Shiff, S.J., Qiao, L., Tsai, L.L. and Rigas, B. (1995) Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest., 96, 491-503.
40. Pasricha, P.J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A.J., Zahurak, M.L., Piantadosi, S., Hamilton, S.R. and Giardiello, F.M. (1995) The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109, 994-998.
41. Jacoby, R.F., Marshall, D.J., Newton, M.A. et al. (1996) Chemoprevention of spontaneous intestinal adenomas in the APC-Min mouse by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56, 710-714.